Sonoporation: from the lab to human clinical trials - Archive ouverte HAL
Communication Dans Un Congrès Année : 2014

Sonoporation: from the lab to human clinical trials

Résumé

Therapeutic ultrasound has been in use for over 70 years but has primarily been a thermal modality. Sonoporation, the use of ultrasound and stable gas microbubbles in the size range of 2-10 µm to form transient pores in cell membranes, has been of great interest in the past 15 years. This technique could be used to improve the delivery of current drugs in very localised regions. There are several phenomena behind sonoporation that all occur non-exclusively: push, pull, jetting, inertial cavitation, shear and, translation. Pre-clinical work has shown that sonoporation can be used to reduce primary tumour burden and inhibit metastatic development. Our clinical trial showed that ultrasound in combination with microbubbles and chemotherapy can effectively double the number of chemotherapy cycles patients can undergo, meaning that the patients were healthier for a longer period of time. Nevertheless, sonoporation is still in its infancy and there is vast room for improvement in both the areas of microbubbles and ultrasound.
Fichier principal
Vignette du fichier
2014 Kotopoulis IEEE IUS846.pdf (1.79 Mo) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03193064 , version 1 (11-04-2021)

Identifiants

Citer

Spiros Kotopoulis, Georg Dimcevski, Bjørn Tore Gjertsen, Odd Helge Gilja, Emmet Mc Cormack, et al.. Sonoporation: from the lab to human clinical trials. 2014 IEEE International Ultrasonics Symposium (IUS), Sep 2014, Chicago, United States. pp.846-849, ⟨10.1109/ULTSYM.2014.0208⟩. ⟨hal-03193064⟩
51 Consultations
134 Téléchargements

Altmetric

Partager

More